BYOT Byotrol Plc

TIDMBYOT

RNS Number : 6051B

Byotrol PLC

21 September 2018

Byotrol plc

("Byotrol", the "Company" or the "Group")

Result of AGM

The Company is pleased to announce that at its AGM held earlier today, all resolutions put to the AGM were duly passed.

Enquiries:

David Traynor - Chief Executive, Byotrol plc

01925 742 000

David Paton - Investor Relations

07714 190 474

finnCap Ltd

020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne - Corporate Finance

Richard Chambers - Corporate Broking

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGLLFIEAIILFIT

(END) Dow Jones Newswires

September 21, 2018 11:00 ET (15:00 GMT)

Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024

Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024